Distinct Implications of TP53 Hits for Patients with Treatment-Related MDS and AML

被引：0

作者：

Kuzmanovic, Teodora ^{[1
]}

Patel, Bhumika J. ^{[2
]}

Nagata, Yasunobu ^{[3
]}

Awada, Hassan ^{[4
]}

Hirsch, Cassandra M. ^{[3
]}

Przychodzen, Bartlomiej P. ^{[1
]}

Sanikommu, Srinivasa Reddy ^{[5
]}

Williams, Louis ^{[1
]}

Mukherjee, Sudipto ^{[2
]}

Advani, Anjali S. ^{[2
]}

Nazha, Aziz ^{[6
]}

Gerds, Aaron T. ^{[7
]}

Radivoyevitch, Tomas ^{[3
]}

Carraway, Hetty E. ^{[8
]}

Sekeres, Mikkael A. ^{[1
]}

Maciejewski, Jaroslaw P. ^{[3
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH 44106 USA

[3] Cleveland Clin Fdn, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, 9500 Euclid Ave, Cleveland, OH 44195 USA

[4] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Fairview Pk, OH USA

[5] Carolinas Healthcare Syst, Dept Hematol Oncol & Blood Disorders, Levine Canc Inst, Charlotte, NC USA

[6] Cleveland Clin, Cleveland, OH 44106 USA

[7] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[8] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-120059

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4353

引用

页数：4

共 50 条

[21] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
Hussaini, Mohammad
Abuel-Haija, Mohammad
Padron, Eric
David, Sallman
Song, Jinming
MODERN PATHOLOGY, 2018, 31 : 524 - 525
[22] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
Hussaini, Mohammad
Abuel-Haija, Mohammad
Padron, Eric
David, Sallman
Song, Jinming
LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
[23] Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation
Duranjou, Marine
Castoldi, Cecile
Alary, Anne Sophie
Hicheri, Yosr
Saillard, Colombe
Rouzaud, Camille
Charbonnier, Aude
Mohty, Bilal
D'Incan, Evelyne
Rey, Jerome
Devillier, Raynier
Vey, Norbert
Gelsi-Boyer, Veronique
Lhoumeau, Anne-Catherine
Murati, Anne
Golesi, Florence
Mozziconacci, Marie Joelle
Ittel, Antoine
Garciaz, Sylvain
BLOOD, 2023, 142
[24] TP53 mutations and Azacitidine treatment: To be or not to be related?
Rigolin, Gian Matteo
Cuneo, Antonio
LEUKEMIA RESEARCH, 2014, 38 (07) : 727 - 728
[25] Autologous stem cell transplantation for treatment-related MDS/AML
Kröger, N
Brand, R
van Biezen, A
Niederwieser, D
Zander, A
de Witte, T
BONE MARROW TRANSPLANTATION, 2003, 31 : S31 - S31
[26] Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation
冯丹
China Medical Abstracts(Internal Medicine), 2023, 40 (03) : 189 - 189
[27] TP53 mutations and MDS - not as easy as it seems
Haase, D.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 7 - 8
[28] Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
Ferrari, Anna
Fonzi, Eugenio
Fontana, Maria Chiara
Di Rora, Andrea Ghelli Luserna
Manfrini, Marco
Padella, Antonella
Baldazzi, Carmen
Papayannidis, Cristina
Marconi, Giovanni
Paolini, Stefania
Guadagnuolo, Viviana
Perricone, Margherita
Robustelli, Valentina
Imbrogno, Enrica
Franchini, Eugenia
Venturi, Claudia
Zuffa, Elisa
Abbenante, Maria Chiara
Simonetti, Giorgia
Testoni, Nicoletta
Ottaviani, Emanuela
Giovanni, Martinelli
CANCER RESEARCH, 2017, 77
[29] Interdependency between TP53 mutational status, genetic instability and prognosis in MDS and secondary AML
Schaab, R.
Ganster, C.
Dierks, S.
Parra, Tallo M.
Martin, R.
Germing, U.
Platzbecker, U.
Shirneshan, K.
Lange, F.
Kroeger, N.
Doehner, K.
Glass, B.
Bacher, U.
Haase, D.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 236 - 236
[30] INFLUENCE OF TP53 MUTATIONS ON HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML)
Goehring, G.
Salari, A.
Thomay, K.
Hagedorn, M.
Schambach, A.
Schlegelberger, B.
LEUKEMIA RESEARCH, 2015, 39 : S75 - S76

← 1 2 3 4 5 →